ArticleFrontiers in pharmacology2025

Berberine protects against gefitinib-induced liver injury by inhibiting the HMGB1/TLR4/NF-κB pathway.

Qiongyin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.